Nine Chapters Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-590
Closed -$56K 199
2017
Q1
$56K Buy
590
+125
+27% +$11.7K 0.08% 218
2016
Q4
$34K Buy
465
+364
+360% +$27.8K 0.06% 166
2016
Q3
$11K Buy
+101
New +$13.9K 0.08% 72
2015
Q4
Sell
-829
Closed -$557K 626
2015
Q3
$557K Buy
829
+349
+73% +$248K 0.05% 532
2015
Q2
$320K Buy
480
+306
+176% +$202K 0.03% 698
2015
Q1
$117K Buy
+174
New +$115K 0.01% 879
2014
Q4
Sell
-247
Closed -$147K 1238
2014
Q3
$147K Sell
247
-86
-26% -$59.5K 0.01% 894
2014
Q2
$218K Buy
333
+105
+46% +$69.6K 0.02% 806
2014
Q1
$179K Sell
228
-6
-3% -$4.87K 0.02% 731
2013
Q4
$180K Buy
+234
New +$176K 0.02% 724

Other funds holding MTEM

Nine Chapters Capital Management's MTEM Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2017, closing a stake of 590 shares — an estimated $56K sold.

Nine Chapters Capital Management first reported a position in MTEM in Q4 2013 and held it in 10 quarters. The position peaked at $557K in Q3 2015. 37 funds tracked by Wall St. Rank hold MTEM as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Molecular Templates, Inc. position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 590 Molecular Templates, Inc. shares in Q2 2017, an estimated $56K.
  • Nine Chapters Capital Management first reported a position in Molecular Templates, Inc. in Q4 2013 and held it in 10 quarters.
  • Nine Chapters Capital Management's Molecular Templates, Inc. position peaked at $557K in Q3 2015.
  • 37 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.